Drug Makers Circumvent Co-Pays Using Rebates

Here’s a perfect example of how all of the stakeholders in our Sickness Industry are pitted against one another:

Here’s how a co-pay for a medicine is supposed to work: Insurers set up a tiered system where patients fork over a smaller co-pay for cheaper drugs and a higher one for more expensive, brand-name drugs. The setup is supposed to encourage patients to use cheaper generics.

But the drug makers are disrupting that system, according to the WSJ. Increasingly, they are paying part of patient co-pays for brand-name drugs, forcing insurers to ante up for these pricer drugs.

Insurance companies pay more, therefore patients pay more, and pharmaceutical companies make more. Our System is all about how to do more. Not how to what’s best for individual patients and surely not what’s best for our country’s economic sustainability.